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Abstract
To identify gene expression responses common to multiple pulmonary diseases we collected microarray data for acute lung
inflammation models from 12 studies and used these in a meta-analysis. The data used include exposures to air pollutants;
bacterial, viral, and parasitic infections; and allergic asthma models. Hierarchical clustering revealed a cluster of 383 up-
regulated genes with a common response. This cluster contained five subsets, each characterized by more specific functions
such as inflammatory response, interferon-induced genes, immune signaling, or cell proliferation. Of these subsets, the
inflammatory response was common to all models, interferon-induced responses were more pronounced in bacterial and
viral models, and a cell division response was more prominent in parasitic and allergic models. A common cluster containing
157 moderately down-regulated genes was associated with the effects of tissue damage. Responses to influenza in
macaques were weaker than in mice, reflecting differences in the degree of lung inflammation and/or virus replication. The
existence of a common cluster shows that in vivo lung inflammation in response to various pathogens or exposures
proceeds through shared molecular mechanisms.
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Introduction
Microarray gene expression profiling has become a common
method for gaining insight into molecular disease mechanisms that
are involved in host-pathogen interaction, and the outcome of the
infection process, in terms of development of disease. The
increasing public availability of microarray data allows for
combining data in a meta-analysis, to identify common clusters
of genes induced upon infection. Since most innate immune
responses, especially those to pathogen-associated molecular
patterns, are evolutionary conserved, it is likely that such common
responses can be found. Indeed, it has been shown that under
controlled in vitro conditions macrophages respond to a broad
range of bacteria with a shared gene expression pattern [1] and
similar findings have been described for dendritic cells [2] and
peripheral blood mononuclear cells [3]. The meta-analysis of in
vitro data by Jenner and Young [4] revealed a common infection
cluster across a larger number of pathogens and studies, that
included several genes for which this role was not recognized in the
underlying studies. However, whether these findings in in vitro
infection models are representative for what happens in vivo is
unknown. Our laboratory recently published data on in vivo lung
infection responses to respiratory syncytial virus (RSV) [5] and
Bordetella pertussis [6,7]. Comparing these data sets showed several
similarities as well as differences in the genes involved, although
the kinetics of the responses was completely different [5–7]. To
make additional comparisons and identify a common set of
upregulated genes in different inflammatory diseases of the lung,
we collected additional data for acute lung inflammation models
from literature studies and other studies at our institute. As
interpreting pair wise comparison between models is hampered by
the large data size for each study, our goal was to use the data in a
meta-analysis. Because the number of different pathogens or other
exposures in each group is small compared to e.g. toxicogenomics
experiments, it is not possible to determine pathogen-specific
responses with sufficient certainty. The dataset is, however,
suitable to detect responses common to all – or to a substantial
number of – pathogens, or to reflect the ‘‘acute phase response’’ in
the lung. Therefore, our aim was to employ a meta-analysis to
identify gene expression changes in in vivo lung inflammatory
models that are common to all, or subsets of, inducers of lung
inflammatory lesions and pathogens.
Results
We combined microarray data from 12 studies [5–17] to
compile a table containing gene expression data for 4551 genes
upon 45 treatment conditions causing pulmonary pathology.
These include 4 exposures to chemical (i.e. air pollution) sources,
namely ozone and particulate matter (PM); 12 to bacterial
infection models (including LPS, a mimic of infection); 19 to viral
infections; 5 to parasitic infections; and 5 to allergic asthma
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Hierarchical clustering on the data showed that there was one
cluster showing a similar response pattern across the rodent and
macaque pulmonary inflammation models. This cluster contains
383 genes and is available as supplementary data at the journal’s
website (Supporting Dataset S1). Please note that, because gene
symbols for rodents and macaques differ in which typecase is used,
we will refer to genes in uppercase throughout this paper and
supplementary data to connect to conventions for writing human
gene symbols.
Initial inspection showed that among the 383 genes there were a
considerable number of immune and inflammation-related genes.
Gene Ontology (GO) term enrichment analysis by the DAVID
resource website (http://david.abcc.ncifcrf.gov/) [18,19] showed
that 100 of the 383 genes are annotated with the GO-term
‘‘immune response’’ (Fisher Exact p-value=4.1E-43) and 40 genes
are annotated with the term ‘‘inflammatory response’’ (Fisher
Exact p-value=1.1E-29) (Supporting Dataset S1). Also, the list
shows substantial overlap with genes previously identified in in vitro
experiments on host-pathogen responses. This includes 120 genes
that were previously found by Jenner and Young [4] as being
involved in the host-pathogen response; 82 genes described by
Huang et al. [2] as dendritic cell common responsive genes; 42
genes described by Nau et al. [1] as being induced as part of the
macrophage activation program; and 30 genes described by
Boldrick et al. [3] as common responsive genes in peripheral blood
mononuclear cells (Supporting Dataset S1). The largest overlap
between the in vivo and in vitro responses is found for inflammatory
cytokines and chemokines.
Within the common up-regulated set of 383 genes, several
immunological processes are represented by a substantial number
of genes. These can be summarized in order of decreasing overlap
with the in vitro studies.
The functional class of genes that is most prominently up-
regulated consists of cytokines and chemokines. Among these
genes are interleukins (IL1A, IL1B, IL5, IL6, IL12B, IL13, IL15),
CC-chemokines (CCL2 (MCP1), CCL4 (MIP-1B), CCL5 (RANTES),
CCL7 (MCP3), CCL8 (MCP2), CCL11 (eotaxin), CCL17 (TARC),
CCL19 (MIP-3B), CCL20 (MIP-3A), CCL22), CXC-chemokines
(CXCL1 (GRO1), CXCL2 (MIP-2A), CXCL5, CXCL9 (MIG),
CXCL10 (IP-10), CXCL13) and other cytokines such as CSF1 (M-
CSF), CSF3 (G-CSF), TNF, SPP1 (osteopontin), AREG (amphir-
egulin). These genes not only show a consistent up-regulation in in
vivo pulmonary inflammation studies, but also a clear overlap with
genes found to be induced in vitro [1–4] (Supporting Dataset S1),
corroborating the pivotal role these genes play in response to a
wide range of agents.
A second major group among the up-regulated genes are
interferon-induced genes. These include guanylate binding
proteins 1 and 2 (GBP1 and GBP2), myxovirus resistance 1 and
2( MX1 and MX2), chemokines CXCL9 and CXCL10, indolea-
mine-pyrrole 2,3 dioxygenase (INDO), and tryptophanyl-tRNA
Table 1. Data and studies used in the meta-analysis; including labels used in Figure 1.
Source data Species Exposure Time points, labels
Chemical
Kooter, 2007 mouse ozone A: 12 h
Kooter, 2005 rat Particulate matter B: 2–6 h, C: 15–21 h, D: 24–40 h
Bacterial
Banus, 2007 mouse (two strains : C3H and HcB28) Bordetella pertussis A :C 3 H1d ,B :C 3 H3d ,C :C 3 H5d ,D :
HcB28 1 d, E: HcB28 3 d, F: HcB28 5 d
Lewis, 2008 mouse LPS aerosol G: 4 h
Mycoplasma pulmonis H: 7 d
Pseudomonas aeruginosa I: 2 h
Rosseau, 2007 mouse Streptococcus pneumoniae J :1d ,K :2d ,L :4d
Viral
Janssen, 2007 mouse Respiratory Syncytial Virus A: 1 d, B: 3 d
Kash, 2004 mouse Influenza (three strains: 1918, NC, and WSN) C: 1918 1 d, D: 1918 3 d, E: NC 1 d, F: NC
3d ,G :W S N1d ,H :W S N3d
Rosseau, 2007 mouse Influenza I: 1 d, J: 2 d, K: 4 d
Baskin, 2004 macaque Influenza A: 4 d, B: 7 d
Kobasa, 2007 macaque Influenza (two strains: K173 and 1918) C: K173 3 d, D: K173 6 d, E: K173 8 d, F:
1918 3 d, G: 1918 6 d, H: 1918 8 d
Parasitic
Lewis, 2008 mouse Nippostrongylus brasiliensis A: 5 d
Reece, 2006 mouse Nippostrongylus brasiliensis B :2d ,C :3d ,D :4d ,E :8d
Allergic asthma
Kuperman, 2005 mouse OVA A: 1 d
Lewis, 2008 mouse OVA B: 1 d
Aspergillus extract C: 4 h
Zimmermann, 2003 mouse OVA D: 18 h
Aspergillus extract E: 18 h
doi:10.1371/journal.pone.0002596.t001
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well characterized interferon-induced genes such as IFI27, IFI30,
IFI35, IFIT1, IFIT2, and IFITM3. This set of genes contains both
IFNa/b and IFNc regulated genes. Other markers that are
consistent with activation of the IFNc response are several
immunoproteasome components (PSMB8, PSMB9, PSMB10,
PSME2). Increased expression of interferon-induced genes is
mainly found for bacterial and viral infection models, illustrating
the role of interferon in the innate immunity system’s first line of
defense against both viral and bacterial pathogens. Most of the
genes in this class are also induced in in vitro models (Supporting
Dataset S1).
Although not as strongly induced as the previous classes, several
genes involved in immunological signaling pathways were found to
be consistently up-regulated. These belong to pathways such as
interferon signaling (IFNAR2, IRF1, IRF4, IRF7, ISGF3G, JAK2,
STAT1, STAT2), NF-kB signaling (NFKB2, NFKBIB, NFKBIE,
IKBKE, REL, RELB, TNFAIP3), AP-1 signaling (JUNB, FOS, FOSL1,
FOSL2), MAPK signaling (MAPK13, MYC), and TLR signaling
(TLR2, CD14, MYD88, PIK3CD, PIK3CG,a n dTBK1). These
pathways are interconnected, and several of the genes mentioned
play a role in more than one signaling process. These interconnec-
tions between the various signaling routes makes the immunological
signaling as a whole more robust and may also explain why the
common in vivo response extends across all these pathways and even
several dozens of other transcription factors that are not directly
connected to these pathways. It is interesting to note that although
themajorityofthecommonup-regulatedsignalinggenesactivatethe
immune response, several inhibitorygenesarealso found for the NF-
kB signaling pathway, namely NFKBIB, NFKBIE, TNFAIP3.T h e
expression patterns for these three genes are similar to other signal
transduction genes. This indicates that the induction of these
inhibitory genes is an equally important aspect of the response, as
these genes will help restore the host cell to its normal state when the
inflammatory stimulus is no longer present, thus keeping the system
in check. For the immunological signaling genes, the overlap with in
vitro studies is less pronounced than for cytokines and chemokines
and interferon-induced genes.
In addition to these three groups of immune-related genes, there
are several smaller gene classes involved in the immune or infection
response. These include known inflammation markers (such as
S100A8, S100A9, LCN2, SAA2), genes involved in the complement
cascade (C1QA, C1QB, C3, C3AR1, C5R1), cytotoxicity (GZMA,
GZMB), or tissue remodeling (CHI3L1, MMP8, MMP9, MMP12,
MMP15). Others play a role in immune cell adhesion such as
VCAM1, integrins (ITGAM, ITGAX, ITGB2), or selectins (SELE,
SELL, SELP). Finally, some genes are not exclusive to the immune
system but connect this to other cellular functions such as genes
involved in leukotriene and prostaglandin metabolism (ALOX5AP,
ALOX12, ALOX15, PTGS2, PTGES), nitric oxide metabolism (NOS2
(iNOS)a n dARG2), or protection against oxidative stress (SOD2,
HMOX1). Taken together, these processes play various roles in the
immune or inflammatory response. The finding that a broad range
of immune-related processes are induced across the different
exposure categories shows that the in vivo pulmonary inflammatory
response to various pathogens or exposures proceeds through – at
least partly – shared molecular mechanisms.
Apart from genes involved in immune or infection-related
processes, we also found a substantial number of genes involved in
cell division or proliferation. These include CCNA2, CCNB1, CCNF,
CDC2A, CDC6, CDC20, CDKN1A (P21), CDKN2D, AURKB, BUB1B,
MKI67,a n dUBE2C. For these genes, the strongest induction was
observed for parasitic (helminth) and protein sensitization (allergic
asthma) models. Surprisingly, there was practically no overlap
between these genes and the genes mentioned in in vitro studies,
suggesting a mechanism specific for the in vivo response.
To further characterize gene expression response patterns, the full
4551-gene dendrogram was reduced to the most significant
branches. Using the GeneMaths option Cluster Plot (see Methods
section for details) provided a recommended branch cutoff level of
88% clustersimilarity. Clipping the dendrogramat this level resulted
ina total number of fifteen branches, ranging insizefrom 23 to 1713
genes.Mostof theseshow no apparent induction ordown-regulation
upon exposure or show only a (moderate) change within a single
study (data not shown). Five branches – which together form the
common pulmonary inflammation response cluster of 383 genes –
show an induction pattern that is consistent across multiple studies
and/or exposures (Fig. 1, subset A–E). These five subsets display
different levels and/or patterns of induction (Fig. 1, subset A–E).
Among the five subsets group C, containing 23 genes, shows the
strongest and most common response to lung inflammation in
rodents, even extending to particulate matter. In primate influenza
models this subset is also up-regulated, although not as strong as in
rodent models. GO-term enrichment showed that this is the only
subset clearly enriched for inflammatory response genes (Supporting
Dataset S1). This is also reflected in the regulated genes (Table 2),
which include several known genes involved in inflammatory
response such as the TLR4 co-receptor CD14; inflammatory
cytokines such as IL1B and IL6; and chemokines like CCL2, CCL4,
CXCL9,a n dCXCL10. Additionally, several well-known inflamma-
tion markers were present, including S100A8 and S100A9 (Cal-
granulin A and B), LCN2 (lipocalin 2 or NGAL), and serum amyloid
A2 (SAA2). Pathway analysis by MetaCore (GeneGo, San Diego,
CA) showed a high rank for the pathway ‘‘Toll-like receptor (TLR)
ligands and common TLR signaling pathway leading to cell
proinflammatory response’’, which is consistent with up-regulation
of proinflammatory cytokines and chemokines.
A second subset showing a general response to pulmonary
inflammation is group A. This subset is particularly induced upon
bacteriological and viral infections in mice. Functional and
pathway analysis showed that the genes in this subset are
especially involved in interferon signaling, with the three highest-
ranking MetaCore pathways being ‘‘Antiviral actions of Interfer-
ons’’, ‘‘IFN alpha/beta signaling pathway’’, and ‘‘Antigen
presentation by MHC class I’’. The last of these pathways is also
mediated by interferon gamma through the formation of
immunoproteasomes and the synthesis of the proteasome activator
PA28 [20]. Among the 50 genes in this cluster are genes involved
in interferon signaling such as STAT1 and STAT2, and more than
15 interferon-induced proteins such as myxovirus resistance 1
(MX1), tryptophanyl-tRNA synthetase (WARS), and indoleamine-
pyrrole 2,3 dioxygenase (INDO) (Supporting Dataset S1).
Subset D, containing 29 genes, shows mainly a gene expression
response in parasitic and asthma models in mice. Both of these
models are associated with T helper 2 (Th2) responses [15,17].
DAVID and MetaCore revealed that this is the only subset that is
not enriched for immunological genes. Instead, it is enriched for
cell cycle related genes, especially those involved in cell division
such as cyclins A2, B1, F, and antigen MKI67.
Finally, there are two subsets with a general, although less
pronounced, response. The larger of these is subset B, containing
182 genes. MetaCore indicated that this subset is enriched for
several cytokine and chemokine signaling pathways, such as NF-
AT, NF-kB, and MAPK signaling. This is reflected by the
presence of genes such as IL5, IL13, NFKB2, NFKBIB, and
MAPK13 in this cluster.
The smaller of the two subsets is cluster E, containing 99 genes.
DAVID and MetaCore analysis indicated that this subset contains
Common Lung Response
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pathways were ‘‘Classic complement pathway’’, ‘‘Lectin Induced
complement pathway’’, and ‘‘Alternative complement pathway’’,
based on complement and integrin genes such as C1QA, C1QB, C3,
C3AR1, ITGAM, ITGAX, and ITGB2. Other immunological genes
in this subset include CCL8, AREG, and NFKBIE. Unlike the other
subsets, which are induced in rodents and (albeit to a lesser extent)
in macaques, this subset is not induced in macaques but only in the
rodent models.
In addition to the common set of up-regulated genes, we also
identified a cluster that displayed a general down-regulation. This
cluster (which we will refer to as subset Z) contained 157 genes.
DAVID and MetaCore showed this subset was enriched for
development-related terms such as cell differentiation, organ
development, blood vessel development, and growth factor activity.
Some of the genes involved in these processes include BDNF, BMP4,
FGF1, FIGF, IGFBP3, TNNI3,a n dWNT3A. Other processes that
were overrepresented in this subset are muscle contraction and
several metabolic processes. Only three immunological genes (CD81,
PLUNC, EFNB1) were found among this subset. A complete listing of
this subset is available as supplementary data at the journal’s website
(Supporting Dataset S2).
Discussion
Combining gene expression data from multiple studies creates
the possibility to compare effects and look for common or specific
responses. In this study, we focused on in vivo acute lung
inflammation models. We included allergic asthma models and
exposures to air pollutants, as these also cause pulmonary
inflammation and therefore provide gene expression data to
which the nature and the extent of infection responses can be
compared. When data from different studies are combined, it
should be kept in mind that not al studies are equally comparable,
as there are differences between inflammation models as well as
between species, time points, as well as other practical details on
how the study was performed. However, combining studies also
results in a larger data set, which allows for an analysis to reveal
additional information that would not be apparent in the original
studies used. When more microarray data on pulmonary
inflammation models will become available in the future, it can
therefore be expected that the number of identifiable common and
specific responsive genes and pathways will increase.
When different studies employ different methods in analyzing
raw data this can cause unwanted (study-dependent) differences on
the normalized data. For this reason we used the same
normalization procedure on all raw two-color array data.
Downloaded Affymetrix data were already normalized according
to standard methods. Also, as the included studies used several
kinds of microarrays, the initially collected data contain a large
number of genes (mostly ESTs) for which only data from one or
two studies are available. Therefore, to reduce the influence of
missing data on the analysis, we also applied a filtering on the set
of included genes, as described in the Methods section. The
criteria were chosen so that a sufficiently large number of genes
was included and small adjustments to the criteria had only a
minor effect on the resulting clustering (data not shown).
The data used contained information for 45 compared
exposures that could be grouped into five main categories, namely
chemical (air pollution related), bacterial, viral, parasitic, and
Figure 1. Gene sets with common expression responses. Fragment of the hierarchical clustering dendrogram containing the abridged clusters for
five common up- (A–E) and one down-regulated (Z) gene cluster. Expression changes compared to control levels are indicated by the color bar and
corresponding ratio: green represents down-regulation, yellow no difference, red up-regulation. The heat map color gradient within each block indicates
the variation within that block. Full details on the exposures used and the corresponding labels can be found in Table 1 and Supporting Table S1.
doi:10.1371/journal.pone.0002596.g001
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cluster of 383 genes with a similar in vivo response pattern
characterizing acute lung inflammation. Of these 383 genes, 120
were previously identified as belonging to an in vitro common
infection response [4]. Within this cluster there were subsets
associated with more specific functional roles such as the response
to bacterial and viral infection (subset A), cytokine and chemokine
signaling (subset B), general inflammatory response (subset C), and
the response to parasites and allergic asthma models (subset D). A
closer analysis on these subsets could enable us to identify new
genes that are of mechanistic importance and suitable as
biomarkers to evaluate infection with unknown pathogens.
When we compare gene expression profiles for the various
exposures, it becomes apparent that the differences within each
treatment category were smaller than those between categories.
This indicates that in addition to a general common infection
response there are additional, more dedicated, responses for
categories of pathogens or treatments. An example of this is the
difference we observed between responses to parasitic versus
bacterial or viral infection. Although further elucidation of such
responses would require data from a larger number of infection
studies, the five subsets identified could serve as an initial starting
point to see which processes are associated with a shared infection
response to all or some categories of exposure.
Among the chemical exposures, the most pronounced response
was observed for subset C. This subset is involved in a general
inflammatory response to pathogens, allergic asthma, and even air
pollutants. An inflammation-related gene expression response to
air pollutants corresponds to the finding that both particulate
matter (PM) and ozone cause lung inflammatory and cytokine
responses [11,12]. The response to ozone in the several subsets is
both up- and down-regulated. This can be explained by the finding
that in addition to an inflammatory response, ozone also causes
suppression of immune responsive genes [12,21]. It has been
suggested that the inflammatory response to PM is caused by the
presence of bacterial endotoxins such as LPS in particulate matter
[22–24]. Indeed, the response to PM correlates best with the
bacterial infection models (including a mimic of infection, LPS), as is
visualizedinFig.1.OurdataunderlinethattheresponsetoLPSmay
be an important element of the response to PM.
Bacteria induce gene expression in several subsets, and the
response to LPS aerosol matches the other responses to bacterial
infection in these subsets. Even though LPS aerosol is not an actual
infection, it mimics exposure to a pathogen and accordingly
induces an inflammatory response. Interestingly, this response is
not strictly LPS-specific as the bacterial infections used include not
only gram negative (Bordetella, Pseudomonas) bacteria, but also the
LPS-lacking Mycoplasma and Streptococcus. This indicates that the
response to bacterial infection is not only dependent on LPS
signaling via TLR4 but signaling through other Toll-like receptors
also plays an important role.
A shared response in non-immunological genes was observed
for parasitic (helminth) and protein sensitization (allergic asthma)
models. Considering that both induce a Th2 response, this is not
surprising. However, subset D, which shows the strongest response
upon these exposures, did not include any Th2-associated
cytokines, suggesting that the major expression changes take place
downstream of Th2 cytokine signaling. The shared response
between helminth infection and allergic asthma involves increased
expression of cell cycle-related genes. In these models there is
apparently a more rapid turnover or proliferation of cells than in
other models. This can be explained by an increased lung
epithelial renewal or proliferation, or alternatively by an increase
in proliferation for immune cells involved. Although the latter
possibility is feasible, the former matches known clinical pathology
for asthma models. Asthma is associated with hyperplasia of the
mucin-secreting goblet cells [25] and in the studies used this is also
described for asthma as well as helminth infection [14,15]. This is
in agreement with the finding that these genes are not found to be
induced in in vitro models using isolated immune cells.
As pulmonary inflammation often involves leukocyte infiltra-
tion, it raises the question whether the common responses occur
primarily in sessile lung cells or can be attributed to infiltrating
immune cells. Although the common upregulated cluster contains
some markers associated with monocytes and macrophages (e.g.
CD14, CD68) or lymphocytes (e.g. CD72, CD80), these do not show
a parallel expression pattern, as would be expected if the gene
expression responses are caused by cellular influx. In addition, the
common cluster does not include several other markers associated
with these types of immune cells, nor those associated with
granulocyte lineages, even though several of these are present in
the initial 4551 gene set used (e.g. CD36, CD19, CD3E, CD7, CD4,
CD8A, MPO). For these markers that are not part of the common
cluster, the expression changes to the controls are much weaker
than those in the common cluster and the responses are also much
less consistent across the various models (data not shown). Finally,
two of the studies include time points where gene expression
responses are at their maximum before a detectable cellular influx
is found by pathological analysis, namely the response one day
after RSV infection [5] and the early response (2–6 h) after PM
Table 2. Subset C of the common lung inflammation
response, containing the 23 genes with the strongest and
most common response across the various pathogens and
exposures.
Symbol Gene Name
CCL2 Chemokine (C-C motif) ligand 2
CCL4 Chemokine (C-C motif) ligand 4
CCL7 Chemokine (C-C motif) ligand 7
CD14 CD14 antigen
CXCL1 Chemokine (C-X-C motif) ligand 1
CXCL2 Chemokine (C-X-C motif) ligand 2
CXCL5 Chemokine (C-X-C motif) ligand 5
CXCL9 Chemokine (C-X-C motif) ligand 9
CXCL10 Chemokine (C-X-C motif) ligand 10
FCER1G Fc receptor, IgE, high affinity I, gamma polypeptide
FCGR3 Fc receptor, IgG, low affinity III
GBP2 Guanylate binding protein 2, interferon-inducible
IFIT1 Interferon-induced protein with tetratricopeptide repeats 1
IL1B Interleukin 1, beta
IL1RN Interleukin 1 receptor antagonist
IL6 Interleukin 6 (interferon, beta 2)
LCN2 Lipocalin 2
S100A8 S100 calcium binding protein A8 (calgranulin A)
S100A9 S100 calcium binding protein A9 (calgranulin B)
SAA2 Serum amyloid A2
TGFBI Transforming Growth Factor, beta-Induced, 68 kDa
TGTP T-cell specific GTPase
TIMP1 TIMP metallopeptidase inhibitor 1
doi:10.1371/journal.pone.0002596.t002
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infection response can be predominantly attributed to gene
expression changes in sessile pulmonary cells rather than to
leukocyte influx.
Besides a common up-regulated cluster, we also identified a
cluster characterized by a common down-regulation in response to
inflammation. This cluster contained a large number of genes
involved in growth and development, both of which are important
processes for continuous renewal of lung epithelium. As can be
seen from Fig. 1, the extent of the down-regulation in this cluster is
moderate compared to the effects in the common up-regulated
subsets. This suggests that the effects found are not a direct
targeted response, but rather a secondary effect that reflects tissue
damage or that the induction of an inflammatory response goes at
the expense of normally active processes in lung tissue. The finding
that the degree of down-regulation is strongest in groups with a
stronger up-regulation for subsets A–D and especially E
corroborates this assumption.
In comparison with the transcriptional changes found in mice,
the effects in primates are generally weaker. More specifically, the
inflammatory response-related subset C, which shows the strongest
response in mice, shows considerably less up-regulation in
macaques. The degree of induction for the interferon signaling-
related subset A is also reduced, albeit to a lesser extent. The other
subsets show a more moderate response to influenza in both mice
and macaques and for these subsets the difference in response is
comparatively small, although it is interesting to note that the
induction of subset E is virtually absent in macaques. A minor
difference in effect is also found for subset Z, which is down-
regulated in mice as well as macaques. These differences in
expression response can not be ascribed to mere study differences
as the effect was reproducible in two studies carried out with
different species, namely cynomolgus macaques (Macaca fascicularis)
in the study by Kobasa et al. [10] and pigtailed macaques (Macaca
nemestrina) in the Baskin et al. [8] study. It can not be ascertained
whether these differences are characteristic for either influenza or
macaques, as microarray data for primate infections with other
pathogens were not available. However, it is likely that differences in
expression response between mice and macaques can be explained
by different disease characteristics between these species. First,
differences in effect are most distinct for the two subsets (A and C)
where the mouse response upon influenza is strongest, which suggest
an association between these responses and disease severity. Second,
the influenza studies in mice [9,16] both reported more severe lung
inflammation and pathology than those in macaques [8,10]. In
macaques, the most severe pathology was observed in those infected
with the 1918 virus strain. Of the three influenza strains used in the
macaque studies, this particular strain causes a gene expression
response that compares best to the common mouse response. This
corroborates our assumption that the different expression response
between rodents and macaques reflects the extent in which lung
tissue is infected and/or the virus multiplies.
In conclusion, our study shows that there is a shared in vivo
expression response to different inducers of lung inflammation.
This response comprises several processes involved in host defense
and inflammation, and the extent of the response represents the
degree of lung inflammation. Our meta-analysis shows consider-
able overlap with findings from in vitro studies (Supporting Dataset
S1), especially in cytokines, chemokines, and interferon-induced
genes. Some of the differences can be attributed to complex cell-
cell interactions, that are absent from in vitro systems, such as the
induction of the cell division-related subset D. However, as
additional microarray data will allow for a more powerful meta-
analysis that reveals more common genes for both the in vivo and in
vitro response, genes that do not overlap between the common in
vivo and in vitro response will not always be specific for either
response and merely represent the developing knowledge in this
field. In the future, additional microarray data from rodents,
primates, and perhaps other mammals will contribute to a further
understanding of the common in vivo response and, ultimately,
identification of disease mechanisms that are unique to specific
agents or pathogens.
Methods
We searched Pubmed, GEO (www.ncbi.nlm.nih.gov/geo/), and
ArrayExpress (www.ebi.ac.uk/arrayexpress/) for gene expression
profiling studies related to acute lung inflammation. If corresponding
microarray data were available, they were downloaded from
websites indicated by the authors. Data were included in the meta-
analysis if they met the following conditions: (a) complete microarray
raw or normalized data are available; (b) a suitable uninfected or
mock infection control is included in the study; (c) time points are at
most eight days after infection (to exclude chronic effects).
Furthermore, we excluded experiments with transgenic pathogens
or hosts focused on specific research questions, as these typically
show inflatedresponsesthatare not representative ofnormal disease.
Based on thesecriteria,we included 45treatmentconditions from12
experiments [5–17]. Of these studies, 4 were carried out in our
laboratory and 8 were from the literature. Note that we count the
data from the two related articles by Banus et al. as one study. Full
details of the studies are given in Table 1.
Affymetrix probe sets identifiers were converted to gene symbols
using probe set annotation data downloaded from the Affymetrix
website (www.affymetrix.com). When necessary, gene symbols in
two-color or Affymetrix data files were adjusted to remove tags
such as ‘‘predicted’’ and converted to uppercase symbols for
further handling. All further calculations were carried out in R
[26] or Microsoft Excel. To minimize the influence of data
handling procedures, we normalized all raw two-color data with
the same algorithm [5,27]. This consisted of a four-step approach
of (1) natural log transformation, (2) quantile normalization of all
scans, (3) taking the sample/reference ln-ratio, and (4) averaging
replicate spot data. To remove negative values and inflated ratios,
MAS4 normalized Affymetrix data were cut off at a lower value of
100, based on the findings of Grundschober et al. [28]. MAS5
normalized Affymetrix data were used without adjustment.
Affymetrix data were ln-transformed and values for replicate gene
symbols were averaged. Finally, for all data sets, the average ln-
ratio for treatment to control was calculated per gene. Treatment
ratio data for the various studies were merged into one table. To
minimize the impact of missing data and non-regulated genes on
further analysis, we restricted the initial table of 39312 genes to
4551 genes that were measured in at least 6 out of 12 studies, 30
out of 45 treatment conditions, and had a ratio exceeding 61.5 in at
least one condition. Hierarchical clustering on these 4551 genes was
performed in GeneMaths (Applied Maths, St-Martens-Latem,
Belgium), using Euclidian distance and Ward linkage. The
GeneMaths option Cluster Plot was used to plot the logarithm of
the cluster size versus the cluster similarity. This method typically
results in a graph with data points that lie closely along a curve that
dropsoff sharplyata level where the number of branches issufficient
to show enough detail, but increasing the number of branches does
not result in much additional information. This level can be
considered as a recommended cluster similarity cutoff. The resulting
value of 88% cluster similarity was used to abridge dendrogram
branches above this similarity value. The resulting dendrogram was
usedtoidentifybranchesorclusterswithup-ordown-regulationthat
Common Lung Response
PLoS ONE | www.plosone.org 6 July 2008 | Volume 3 | Issue 7 | e2596cover multiple studies or pathogens and therefore indicate a
common response.
Functional annotation and Gene Ontology (GO) term enrich-
ment analysis were performed with the DAVID website (http://
david.abcc.ncifcrf.gov/) [18,19]. For GO-term enrichment, the
functional annotation clustering option was used, with default
settings. Functional annotation terms were considered enriched for
an Enrichment Score larger than 3, which corresponds to a
geometric average p-value of 0.001. MetaCore (GeneGo, San
Diego, CA) was used for additional pathway enrichment and
visualization.
Supporting Information
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